Live News EARNINGS ARTICLE L impact Aug 04, 2026, 08:03 PM UTC

Pacira BioSciences Lowers FY2026 Sales Guidance from $745.000M-$770.000M to $735.000M-$760.000M vs $766.384M Est

Pacira BioSciences (NASDAQ: PCRX ) lowers FY2026 sales outlook from $745.000 million-$770.000 million to $735.000 million-$760.000 million vs $766.384 million estimate.

PCRX

SquawkNews Newsroom

Pacira BioSciences (NASDAQ: PCRX ) lowers FY2026 sales outlook from $745.000 million-$770.000 million to $735.000 million-$760.000 million vs $766.384 million estimate.